Literature DB >> 26019439

Sphincter of Oddi dysfunction Type III: New studies suggest new approaches are needed.

C Mel Wilcox1.   

Abstract

Sphincter of Oddi dysfunction (SOD) has been classified into three types based upon the presence or absence of objective findings including liver test abnormalities and bile duct dilatation. Type III is the most controversial and is classified as biliary type pain in the absence of any these objective findings. Many prior studies have shown that the clinical response to endoscopic therapy is higher based upon the presence of these objective criteria. However, there has been variable correlation of the manometry findings to outcome after endoscopic therapy. Nevertheless, manometry and sphincterotomy has been recommended for Type III patients given the overall response rate of 33%, although the reported response rates are highly variable. However, all of the prior data was non-blinded and non-randomized with variable follow-up. The evaluating predictors in SOD study - a prospective randomized blinded sham controlled one year outcome study showed no correlation between manometric findings and outcome after sphincterotomy. Furthermore, patients receiving sham therapy had a statistically significantly better outcome than those undergoing biliary or dual sphincterotomy. This study calls into question the whole concept of SOD Type III and, based upon prior physiologic studies, one can suggest that SOD Type III likely represents a right upper quadrant functional abdominal pain syndrome and should be treated as such.

Entities:  

Keywords:  Abdominal pain; Manometry; Sphincter of Oddi dysfunction; Sphincterotomy

Mesh:

Year:  2015        PMID: 26019439      PMCID: PMC4438009          DOI: 10.3748/wjg.v21.i19.5755

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  49 in total

Review 1.  Exploring the use of the sham design for interventional trials: implications for endoscopic research.

Authors:  C Mel Wilcox
Journal:  Gastrointest Endosc       Date:  2008-01       Impact factor: 9.427

Review 2.  Dysmotility disturbances of the biliary tract: classification, diagnosis, and treatment.

Authors:  W J Hogan; J E Geenen; W J Dodds
Journal:  Semin Liver Dis       Date:  1987-11       Impact factor: 6.115

3.  Measuring episodic abdominal pain and disability in suspected sphincter of Oddi dysfunction.

Authors:  Valerie Durkalski; Walter Stewart; Paulette MacDougall; Patrick Mauldin; Joseph Romagnuolo; Olga Brawman-Minzter; Peter Cotton
Journal:  World J Gastroenterol       Date:  2010-09-21       Impact factor: 5.742

4.  Outcome of endoscopic sphincterotomy in post cholecystectomy patients with sphincter of Oddi dysfunction as predicted by manometry and quantitative choledochoscintigraphy.

Authors:  M Cicala; F I Habib; P Vavassori; N Pallotta; O Schillaci; G Costamagna; M P L Guarino; F Scopinaro; F Fiocca; A Torsoli; E Corazziari
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

5.  Long-term results (≥ 10 years) of endoscopic therapy for sphincter of Oddi dysfunction in patients with acute recurrent pancreatitis.

Authors:  T Wehrmann
Journal:  Endoscopy       Date:  2010-11-24       Impact factor: 10.093

Review 6.  Functional gallbladder and sphincter of oddi disorders.

Authors:  Jose Behar; Enrico Corazziari; Moises Guelrud; Walter Hogan; Stuart Sherman; James Toouli
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

Review 7.  Functional abdominal pain syndrome.

Authors:  Ray E Clouse; Emeran A Mayer; Qasim Aziz; Douglas A Drossman; Dan L Dumitrascu; Hubert Mönnikes; Bruce D Naliboff
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

8.  Blinding in randomised trials: hiding who got what.

Authors:  Kenneth F Schulz; David A Grimes
Journal:  Lancet       Date:  2002-02-23       Impact factor: 79.321

9.  Risk factors for complications after ERCP: a multivariate analysis of 11,497 procedures over 12 years.

Authors:  Peter B Cotton; Donald A Garrow; Joseph Gallagher; Joseph Romagnuolo
Journal:  Gastrointest Endosc       Date:  2009-03-14       Impact factor: 9.427

10.  Intraluminal pressure recording from the human sphincter of Oddi.

Authors:  J E Geenen; W J Hogan; W J Dodds; E T Stewart; R C Arndorfer
Journal:  Gastroenterology       Date:  1980-02       Impact factor: 22.682

View more
  8 in total

1.  Increased Risk of Acute Pancreatitis with Codeine Use in Patients with a History of Cholecystectomy.

Authors:  Juhyeun Kim; Andrew John Tabner; Graham David Johnson; Babette A Brumback; Abraham Hartzema
Journal:  Dig Dis Sci       Date:  2019-08-29       Impact factor: 3.199

Review 2.  [Importance of functional diagnostics in gastroenterology].

Authors:  M Hollenbach; A Hoffmeister; J Rosendahl; J Mössner
Journal:  Internist (Berl)       Date:  2018-01       Impact factor: 0.743

Review 3.  Idiopathic acute pancreatitis: a review on etiology and diagnostic work-up.

Authors:  Giovanna Del Vecchio Blanco; Cristina Gesuale; Marzia Varanese; Giovanni Monteleone; Omero Alessandro Paoluzi
Journal:  Clin J Gastroenterol       Date:  2019-04-30

Review 4.  Update on Sphincter of Oddi Dysfunction: A Review.

Authors:  Jaimy Villavicencio Kim; George Y Wu
Journal:  J Clin Transl Hepatol       Date:  2022-01-11

5.  Diagnosis and Therapeutic Management in Postcholecistectomy Alithiasic Cholangitis.

Authors:  Mariana Ungur; Petru Aurel Babes; Adrian Maghiar; Gheorghe Mircea Pop; Bogdan Feder
Journal:  Maedica (Buchar)       Date:  2019-09

Review 6.  Translational and clinical perspectives on sphincter of Oddi dysfunction.

Authors:  Kondal Rao Kyanam Kabir Baig; Charles Melbern Wilcox
Journal:  Clin Exp Gastroenterol       Date:  2016-07-28

7.  Gall Bladder Agenesis: A Rare Embryonic Cause of Recurrent Biliary Colic.

Authors:  Aarthi Rajkumar; Albina Piya
Journal:  Am J Case Rep       Date:  2017-04-02

8.  Gallbladder Agenesis without Additional Biliary Tracts Abnormality.

Authors:  Seyed Mostafa Meshkati Yazd; Hamidreza Bayati; Sara Sadat Nabavizadeh; Reza Shahriarirad
Journal:  Case Rep Gastrointest Med       Date:  2022-06-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.